Latest news
Amplia Therapeutics partners with Lilly on lung cancer combination trial - Proactive financial newsProactive financial news · Tue, 04 Aug 2026 03:12:34 GMTAmplia Therapeutics Partners with Eli Lilly in FAK-KRAS Combination Lung Cancer Trial - smallcaps.com.ausmallcaps.com.au · Tue, 04 Aug 2026 00:44:05 GMTAmplia announces agreement with Lilly to test narmafotinib combination in lung cancer - biotechdispatch.com.aubiotechdispatch.com.au · Mon, 03 Aug 2026 22:59:39 GMT